We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

The Bharat Immunologicals and Biologicals Corporation Limited (BIBCOL) is a Central Public Sector Unit, under the Department of Biotechnology, Ministry of Science and Technology. BIBCOL was ...

* Bharat Immunologicals and Biologicals Corporation Ltd - sept quarter net profit 15.5 million rupees versus loss 24.8 million rupees year ago Sign up here. * Bharat Immunologicals and Biologicals ...

1 Day 524663 -3.51% DJIA 0.48% S&P Mid Cap 400 0.85% Health Care/Life Sciences -0.21% ...

Bharat Immunologicals and Biologicals's latest twelve months ebitda is zero Bharat Immunologicals and Biologicals's ebitda hit its 5-year low in March 2021 of -208.4 million. Bharat Immunologicals and ...